nDash.com is a content creation platform that provides brands and agencies with access to the world's top freelance writers.
I'm a content writer and content strategist for B2B and B2C brands in the healthcare and life sciences spaces. With my psychiatry research background, I bring a unique blend of industry expertise and creative finesse to the table, fueled by a passion for distilling complex concepts into accessible content. I've written content for tech startups, healthcare organizations, pharmaceutical manufacturers, insurance businesses, SaaS brands, and more. From crafting SEO-optimized articles to in-depth reports, I ensure your brand's message not only resonates with your target audience, but drives measurable results, be it increased website traffic, qualified leads, or brand awareness.
In this report, we use healthcare commercial intelligence from the Definitive Healthcare platform and research from external sources to understand the rising role of retailers in healthcare, explore the impact of retail clinics on patients and traditional healthcare providers, and consider how traditional providers should respond to these new entrants.
https://www.definitivehc.com/resources/research/retailers-healthcare
Healthcare organizations are still grappling with labor constraints and higher expenses that continue to impact the bottom line, even as health system finances start to move in the right direction. Many healthcare startups built in a low-interest rate environment are now running out of money and facing hard choices. Here's what HCOs should consider to not only stay afloat but thrive in an uncertain economic climate.
https://www.definitivehc.com/blog/how-healthcare-companies-can-thrive-during-downturn
The Inflation Reduction Act will cut costs and improve access to prescription drugs for millions of Americans, but it also creates uncertainty for drugmakers and could reshape the business of drugs in the U.S. In this article, we explore the possible knock-on effects of this new law.
https://www.google.com/url?q=https://www.definitivehc.com/blog/medicare-drug-price-negotiation
More than two years into the pandemic, many hospitals are confronting one of their worst financial years in decades. In this blog, we’ll look at the latest trends shaping hospital finances and discuss actions health systems and hospitals are taking to trim expenses.
https://www.definitivehc.com/blog/healthcare-staffing-problem-hospitals-cutting-jobs
To help address gender inequality in healthcare, a growing number of technology companies are developing solutions specific to women’s health. These solutions make up a subsector of healthcare technology called femtech. It’s still a small segment of the market, but it’s growing. In this article, we look at some of the women’s health challenges femtech is solving and the companies building innovative solutions in this sector.
https://www.definitivehc.com/blog/femtech-tech-womens-health
Digital health startups launched in the pandemic era are facing a moment of reckoning as investors seek a pathway to profitability. Using healthcare data, we can dig into the latest trends shaping the digital health ecosystem and identify opportunities in this shifting landscape.
https://www.definitivehc.com/blog/digital-health-reset
Companies from all industries are looking for ways to capitalize on artificial intelligence. Health insurers are no different. Large payers are testing how to use AI to spot fraud, speed up prior authorization, and guide care management. But alongside its potential, AI introduces a set of challenges that payers must balance to ensure its ethical use.
https://www.definitivehc.com/blog/ai-for-payors
Clinical trials are a crucial testing ground for prospective drugs and devices. They’re also expensive, administratively complex, and enormously time-consuming. In this blog, we'll explore some of the latest trends in clinical trials and consider how these developments could make studies cheaper, faster, and better – and shape clinical testing into the future.
https://www.definitivehc.com/blog/latest-trends-clinical-trials
As the stigma around psychedelics recedes, researchers are exploring the promise of these drugs within broader treatment frameworks for not only mental health disorders like depression but also for Parkinson’s disease, fibromyalgia, and even traumatic brain injury. Here’s a look at trends that could shape the psychedelics landscape in the years ahead.
https://www.definitivehc.com/blog/psychedelic-therapy
The United States is facing an epidemic of drug overdose deaths, with more people dying from overdose deaths in 2014 than in any year on record, according to the Centers for Disease Control and Prevention. And more than 60 percent of the country’s drug overdose deaths involve an opioid, including both prescription opioids and heroin. Scientific research and physicians agree, Medication-Assisted-Treatment (MAT), or the use of medications in combination with counseling and behavioral therapies, is key to tackling the country’s opioid epidemic. Yet as overdose deaths rise, MAT remains severely underutilized...
The shift from the fee-for-service payment structure to fee-for-value payment models is no easy feat. But the transition is proving to be an even more monumental task for behavioral health. Payers tend to view mental health as distinct from physical health and often “carve out” mental health treatment from provider contracts, despite the frequent overlap between mental and physical illnesses. A lack of quality measures and standards for behavioral health treatment presents additional obstacles...
States that opt out of Medicaid expansion under the Affordable Care Act may be undermining access to mental health and addiction services for low-income individuals. Roughly 3 million low-income individual nationwide struggle with behavioral health issues, about half of whom live in Medicaid non-expansion states, according to a report published by the Government Accountability Office. Residents of non-expansion states have not gained access to much needed mental health and addiction services as a result, including psychiatric assessments, outpatient and inpatient treatment, and prescription drugs. And the states themselves are losing on several fronts as well...
Translating healthcare market intelligence into impactful marketing content to establish industry authority, elevate brand presence, and drive business growth.
Company: Definitive Healthcare
I worked there from 9/2022 until now
Researching and reporting on digital health startups, technology investment, and early stage innovation in healthcare for corporate strategy and VC decision makers.
Company: CB Insights
I worked there from 1/2022 until 9/2022